logo
  • PUMA
  • FLARE-UP
  • Resources
image

Welcome to i-Detect!

This portal contains non-invasive screening tools to help you with your patient’s evaluation process and to facilitate the diagnosis of COPD and identify a history of exacerbations

Once you complete the questionnaire on behalf of your patient, you will have more information to take further steps towards their disease management. You will also be able to download and share the results with your patient

PUMA QUESTIONNAIRE

If you suspect your patient may have COPD

FLARE-UP CHECKLIST

If patient is at risk for a COPD exacerbation

image

About i-Detect

 

Despite COPD, a common chronic respiratory disease, being the third leading cause of death worldwide,1,2 it remains underdiagnosed.1,3 Early diagnosis and intervention during the course of COPD can have a positive impact on its prognosis.4

PUMA

image

With symptoms of COPD overlapping with those of other respiratory diseases,1 the increased rate of smoking in low- and middle-income countries1 and limited access to spirometry in some primary care practices,5 a simple questionnaire such as PUMA can be useful in identifying people who need spirometry to confirm or refute COPD diagnosis6,7

 

PUMA has 7 questions related to factors predictive of COPD with weighted responses. A total score of 5 or more indicates the need for spirometry assessment.7

PUMA QUESTIONNAIRE

FLARE-UP

image

COPD is often associated with exacerbations, episodes of acute worsening of respiratory symptoms, which require additional therapy.1 Exacerbations negatively affect the overall health, increase hospitalisation and re-admission rates and contribute to disease progression.1 Exacerbation history is key for predicting the risk of future exacerbations1; The FLARE-UP checklist can help understand the patient’s history of exacerbations

FLARE-UP has 4 questions related to the frequency of rescue medication, antibiotics and oral steroid use, and hospitalisation in the past year. A high frequency of these events indicates a potential exacerbation in the past year.

FLARE-UP CHECKLIST

Resources For You

 

PUMA Questionnaire

image
DOWNLOAD NOW

FLARE-UP Checklist

image
DOWNLOAD NOW

Patient Education

image
VISIT PATIENT INFORMATION

(currently under development)

REFERENCES:

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2025 report. https://goldcopd.org/2025-gold-report-2/. Last accessed: July 2025.

2. World Health Organization. Chronic Obstructive Pulmonary Disease (COPD). https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Last accessed: July 2025.

3. Diab N, et al. Am J Respir Crit Care Med. 2018;198(9):1130─1139.

4. Sun Y, et al. Int J Chron Obstruct Pulmon Dis. 2019;14:1119─1125.

5. Meiwald A, et al. Int J Chron Obstruct Pulmon Dis. 2022;17:1507─1521.

6. López Varela MV, et al. Respirology. 2016;21(7):1227─1234.

7. López Varela MV, et al. Int J Chron Obstruct Pulmon Dis. 2019;14:1901─1911.

For healthcare professionals only.
This website is for information only, and is not to be used for diagnosis or treatment decisions. I-Detect, PUMA score, and FLARE-UP checklist are all developed and funded by AstraZeneca.

Act on COPD Logo

Privacy notice

Cookie notice

Legal notice and terms of use

Contact Us

Astra Zeneca Logo

AstraZeneca Sdn Bhd (69730-X)
The Bousteador, Level 12
No. 10, Jalan PJU 7/6, Mutiara Damansara
47800 Petaling Jaya, Selangor, Malaysia
T: +603 7624 3888
F: +603 7624 3999

ASTRAZENECA VPM ID: MY-16827
|
DATE OF PREPARATION: April 2025
|
DATE OF EXPIRY: April 2027
DATE OF PREPARATION: April 2025  |  DATE OF EXPIRY: April 2027
|
© ASTRAZENECA 2025 ALL RIGHTS RESERVED
Welcome to i-Detect Malaysia

This website is intended to provide healthcare professionals practising in Malaysia with available resources to support clinical practice for COPD.

The dissemination of the information available in this website may be subject to different medical and regulatory requirements in other countries.

The information is provided for educational and reference purposes only. It is not intended for use in the diagnosis or treatment of individual patients.

Are you a healthcare professional practising in Malaysia?

Self Certification Buttons
No, I am patient/public Self Certification Buttons